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Background. Nonstandardized specimen-transport logistics, lack of laboratory personnel to transport specimens, lack of stan-
dard specimen containers, and long turnaround time (TAT) hindered access to quality laboratory services. The objective of the
Becton, Dickinson, and Company (BD)–US President’s Emergency Plan for AIDS Relief (PEPFAR) Public-Private Partnership
(PPP) was to support country-specific programs to develop integrated laboratory systems, services, and quality improvement strat-
egies, with an emphasis on strengthening the specimen-referral system (SRS).
Methods. In 2007, through the Centers for Disease Control and Prevention (CDC), the Ethiopian Public Health Institute (EPHI)
joined with the BD-PEPFAR PPP to strengthen laboratory systems. A joint planning and assessment committee identified gaps in the
SRS for prioritization and intervention and piloted the system in Addis Ababa and Amhara Region.
Results. The PPP established standardized, streamlined specimen logistics, using the Ethiopian Postal Service Enterprise to sup-
port a laboratory network in which 554 facilities referred specimens to 160 laboratories. The PPP supported procuring 400 standard
specimen containers and the training of 586 laboratory personnel and 81 postal workers. The average TAT was reduced from 7 days
(range, 2–14 days) to 2 days (range, 1–3 days) in Addis Ababa and from 10 days (range, 6–21 days) to 5 days (range, 2–6 days) in
Amhara Region.
Conclusions. This study highlights the feasibility and untapped potential of PPPs to strengthen laboratory systems. This planned
and structured approach to improving specimen referral enhanced access to quality laboratory services.
Keywords. specimen-referral system; training; public-private partnership; postal system; turn around time.
In sub-Saharan Africa, the AIDS epidemic exposed the fragile
and fragmented specimen-referral networks within the health
system. The lack of these networks resulted in unacceptably
long turnaround times for laboratory results. Lower-tier labora-
tories in health facilities were not equipped to perform all of the
necessary laboratory tests, and this required referring patient
samples to higher-tiered laboratories that were equipped to do
so. Timely access to and wide availability of human immunode-
ficiency virus (HIV) and tuberculosis diagnosis, treatment, and
monitoring services are key components of improving and pro-
longing the lives of patients, as well as a path toward attaining
the goal of an AIDS-free generation [1–3]. Laboratory services,
which have a key role in disease diagnosis, control, and preven-
tion, have been found to be one of the weakest areas in health-
care-delivery systems in developing countries [4–6]. Through
the Maputo Declaration, ministries of health (MOH) agreed
that the creation of national laboratory networks is essential
to achieve access to quality laboratory services [7, 8].
Increasingly, national laboratory strategic planning efforts
recognize the need for strengthening laboratory systems, includ-
ing human resource and infrastructure development, quality
management, supply chain management, specimen referral,
and results-reporting and laboratory information systems, in
an integrated and coordinated laboratory network [9, 10].
Transportation systems in resource-limited settings are either
nonexistent or insufficient and, in most cases, do not address
the need to transport patient specimens from the district health-
care centers to higher-level testing facilities [11].
Ethiopia’s laboratory structure is well aligned with the struc-
ture of the healthcare-delivery system. The laboratories at each
of the tiers have different testing capacities, with health centers
being the smallest facilities and, therefore, having the smallest
testing capacity, in the national laboratory system. To increase
access to specialized tests, it is important to develop a reliable
laboratory network with a strong specimen-referral system. A
specimen-referral system was first established in 2008 by the
Ethiopian Public Health Institute (EPHI) in collaboration
with the Centers for Disease Control and Prevention (CDC)
under the US President’s Emergency Plan for AIDS Relief
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(PEPFAR) and several implementing partners, such as Johns
Hopkins University (JHU), Columbia University (CU-ICAP),
the University of Washington International Training and Edu-
cation Center for Health (I-TECH), and the University of
California–San Diego (UCSD), to support the massive scale-up
of antiretroviral treatment (ART) to >330 000 patients. The refer-
ral system focused on collecting specimens from patients receiv-
ing ART, for CD4+ T-cell, chemical, hematological monitoring,
and collecting blood specimens from infants, for early diagnosis
of HIV infection by the dried blood spot (DBS) technique. Four
hundred twenty laboratories were referring specimens for ART
monitoring to the healthcare facility at next higher level or to
regional laboratories. There was no dedicated specimen courier
system, with specimens being transported through partner ve-
hicles or public transportation, integrated with mentoring and
supportive supervision visits, leading to significant delay in re-
sults delivery. However, the presence of the specimen-referral
network supported by partners made it easier to implement
the public-private partnership (PPP). The specimen-referral
program was transitioned to the regional health bureaus
in 2010, in line with the decentralization of services, and
financed by the EPHI, using PEPFAR/CDC cooperative agree-
ment funds.
The PEPFAR-supported supply chain management system
worked with the procurement section of the Ethiopian MOH,
the Pharmaceutical Fund and Supply Agency, for regular moni-
toring and forecasting of laboratory commodities, including
specimen-collection tubes and infection-prevention materials.
However, the system was challenged by an underdeveloped trans-
portation system, a lack of specimen-packaging logistics, and
long turnaround times. Additionally, in most instances, laborato-
ry staff were deployed to transport specimens to testing facilities,
thereby leaving laboratories understaffed or unattended. This was
a major problem at health center laboratories in remote sites,
which were usually staffed by 1 or 2 laboratory personnel.
There are examples from some organizations that have de-
scribed approaches to overcome challenges in implementing
quality-assured and timely laboratory services under a well-
coordinated network [12]. However, these organizations have
not successfully addressed these multifaceted challenges compre-
hensively, despite the significant resources and efforts invested
[13]. Addressing the healthcare needs of people in the developing
world requires cooperation, partnerships, and coordination among
various sectors [14]. There was the recognition that the PPP would
build local capacity and contribute to the long-term sustainability
of programs, thus demonstrating the important role that the pri-
vate sector can have in strengthening health systems.
The goal of the BD-PEPFAR PPP with the EPHI/MOH was
to address key gaps in the existing specimen-referral network,
with particular focus on reducing turnaround times, introduc-
ing standard specimen-transport logistics, and increasing access
to quality laboratory services.
METHODS
Assessment and Planning
Prior to the PPP intervention, with the exception of blood spec-
imens collected for analysis by the DBS technique for early di-
agnosis of HIV infection in infants, specimens were transported
by laboratory personnel or implementing partners, using public
transportation. The samples obtained for analysis by the DBS
technique were transported using the postal services network.
The PPP worked closely with the country program in a consul-
tative manner to identify priorities. The core country program
team involved the EPHI and the CDC and its implementing
partners (ie, JHU, CU-ICAP, I-TECH, and UCSD). BD, in col-
laboration with the country team, conducted a baseline assess-
ment using a structured checklist, with particular emphasis on
specimen referral. Additionally, using findings from past assess-
ments of the national laboratory services and considering stra-
tegic initiatives in the National Laboratory Strategic Master
Plan, including informed discussions with the Ethiopian
MOH, the country program team and BD identified key gaps
in the system to address and strengthen the existing speci-
men-referral and result reporting system.
A comprehensive work plan was developed to address the iden-
tified gaps in the existing system, with roles and responsibilities of
the different parties clearly defined. Training laboratory and post-
al service personnel, ensuring an adequate supply of standard
specimen-transport materials, improving physical specimen logis-
tics, and addressing laboratory safety were considered important
priorities under the PPP. In addition, mentoring the facility staff,
using geographic information system (GIS) software and geo-
graphic positioning system (GPS) devices, and monitoring and
evaluating the specimen-referral network were part of the scope
of work for the PPP. The PPP focused on strengthening the exist-
ing specimen-referral systems by directly working with facilities
and partners. Through the leadership role provided by the
EPHI and CDC-Ethiopia, the PPP involved other partners,
such as the Clinton Health Access Initiative (CHAI), Direct Relief
International, and the CDC implementing partners JHU, CU-
ICAP, ITECH, the supply chain management system, and UCSD.
The nonoverlapping coverage of geographic zones by partners
helped to better coordinate specimen referral across regions
(Figure 1). The PPP supported consolidation and integration
of all available specimens and results-reporting mechanisms
into a unified system. However, a phased implementation approach
was deemed logical, and it was initiated in Addis Ababa, the
capital of Ethiopia, and later expanded to Amhara Region.
The successful implementation of the pilot in Addis Ababa and
Amhara Region and the associated lessons learned informed
plans for national scale-up.
Sample Referral Mapping and Training
The EPHI mapped out all specimen-referring sites, specimen
types, and linkages to laboratories where tests would be











performed. This was primarily along regional boundaries, and
the mapping had a key role in establishing a memorandum of
understanding with the EPSE. Under the PPP, the EPHI signed
a memorandum of understanding with the EPSE to transport all
specimens in Addis Ababa and samples obtained for analysis
by the DBS technique nationwide. Under this agreement, the
EPSE, instead of laboratory personnel, transported all samples
from and results to referring facilities enrolled in the pilot pro-
gram. Local post offices and referring heath facilities established
a special delivery route for laboratory specimens. The arrange-
ment was such that the post office worker would visit the health
facility twice weekly to pick up specimens that were available for
transport. Appointments for patients usually occurred during
Monday–Wednesday mornings to avoid specimen transport
near the weekend, and the testing load at facilities was managed
by overtime work and assignment of additional laboratory per-
sonnel based on specimen flow. On these days, the laboratory
personnel collected the specimens, packaged them properly,
and made them ready for pickup by the postal office. Postal
office workers were required to report any incident during
specimen transport for proper corrective actions and use in im-
proving training or refresher trainings of postal workers. Train-
ing materials on specimen referral were developed by BD and
customized by the country team for both laboratory personnel
and postal workers. Standard operating procedures, transport
logs, and safety procedures during transport were developed.
A standard training consisted of an initial assessment of train-
ees, training on documentation and biosafety, and hands-on
instruction with an emphasis on packaging, handling, and
tracking, to ensure the creation of an audit trail. A training-
of-trainers course was provided to establish personnel capacity
and a pool in each of the regions, and a training rollout was con-
ducted in 2 regions by the PPP in collaboration with the EPHI
and the CDC and its implementing partners. The country team
subsequently conducted training rollout to all other regions.
Standard specimen-transport materials (BD isothermal con-
tainers [catalog no. 368 562]) were procured by BD through Di-
rect Relief International and distributed to facilities by the
EPHI. GIS software, laptops, and a server were procured and in-
stalled at the EPHI. Two sessions of training on GIS/GPS were
conducted for EPHI staff, with full implementation of GIS
planned for the second phase.
Tools were developed for regular monitoring and evaluation of
program implementation, with major indicators being turn-
around time, frequency of rejecting transported samples because
they were inadequate for analysis, availability of standard speci-
men-transport containers at referring sites, and the number of
laboratory and postal service personnel trained. Turnaround
time was defined as the time from referral of specimens collected
from ART recipients to a laboratory (for monitoring CD4+
T-cell, chemical, and hematological parameters) to receipt of re-
sults by the referring facility. Turnaround time for early diagnosis
of HIV infection in infants was not part of this analysis.
RESULTS
Activities Before PPP Formation
Prior to the collaborative efforts between the PPP, CDC, and
EPHI, 420 sites were referring specimens obtained from
Figure 1. Regional placement of partners providing site-level technical support for laboratory-system strengthening, including specimen-referral testing, in Ethiopia. Abbre-
viations: ICAP, Columbia University International Center for AIDS Care and Treatment Program; I-TECH, University of Washington International Training & Education Center for
Health; JHU, Johns Hopkins University; SCMS, supply chain management system; UCSD, University of California, San Diego.











patients receiving ART for CD4+ T-cell, chemical, and hemato-
logical monitoring at testing laboratories (Table 1). The average
time for transporting specimens was 4 hours for Addis Ababa
and 6 hours for other regions of Ethiopia, depending on the
locations of the referring and testing sites. There was a need
to procure >2000 standard specimen carriers, following World
Health Organization (WHO) specifications. Only 85 laboratory
personnel and no postal workers were trained in conserving the
integrity of specimens and in protecting themselves from blood-
borne diseases. The average turnaround time for results of tests
among ART recipients (for CD4+ T-cell, chemical, hematological
monitoring) was 7 days (range, 2–14 days) in Addis Ababa and
10 days (range, 6–21 days) elsewhere. There was no standard
specimen-transport option; use of the public transportation sys-
tem was the only option. The availability of standardized and safe
containers for packaging and transporting specimens was in-
adequate. Laboratory personnel were transporting specimens
through the public transportation system in all regions.
Activities After PPP Formation
Training
The EPHI, CDC-Ethiopia, and partners collaborated with BD to
successfully design a tailor-made course for proper packaging
and transport of infectious materials such as blood and sputum.
This course was for laboratory personnel and postal staff. The ini-
tial 2 regional trainings were supported by BD, but the overall
regional training rollout in all regions was conducted by the
country team. There was adequate local capacity established
with the initial training of trainers, which helped yield 30 trained
individuals. Over 2 years, the team of facilitators, composed of
staff from BD, the EPHI, regional laboratories, and partners,
trained 667 participants (586 laboratory personnel and 81 postal
workers) in 11 regions. There was increased awareness by both
laboratory and postal workers on biosafety and occupational ex-
posure preventions. A GIS/GPS system was established at the
EPHI. Fifteen personnel were trained from the EPHI and the
Ethiopian MOH on laboratory, survey and surveillance, and pub-
lic health emergency management programs.
Specimen-Transport Network and Turnaround Time
The EPSE’s services were used in 2 regions, Addis Ababa and
Amhara, to transport all specimens. In these 2 regions, labora-
tory personnel were no longer involved in transporting speci-
mens. This allowed them to focus on providing continuous
laboratory services for clients. In addition, the PPP contributed
by procuring 400 of the 2132 standard triple-packaged specimen
containers per WHO specifications, while PEPFAR procured the
remaining 1732. Following the training intervention, mentorship,
and transitioning the responsibility of specimen transport to the
postal system, specimens collected for ART monitoring now ar-
rived at the closest laboratory within 1 hour after collection
(range, 0.5–2 hours) in Addis Ababa, compared with 4 hours
(range, 2–6 hours) before the intervention. Similarly, a speci-
men obtained for ART monitoring from any referring site in
the region now took an average of 4 hours (range, 1–5 hours)
to reach its closest testing laboratory, compared with 6 hours
(range, 3–14 hours) before the intervention. Following training
of laboratory and postal workers on specimen referral, the turn-
around time was improved to an average of 2 days (range, 1–3
days), compared with 7 days (range, 2–14 days) before the inter-
vention, for specimens referred in Addis Ababa (Table 1). In
other regions where similar trainings were conducted and speci-
men transport and results feedback were provided by the postal
system, preliminary data indicated that, on average, turnaround
time decreased from 10 days (range, 6–21 days) before the in-
tervention to 5 days (range, 2–6 days) after the intervention.
Table 1. Results of Key Interventions Used in Strengthening and Monitoring the Specimen-Referral System in Ethiopia Under the Public-Private
Partnership (PPP) Between Becton, Dickinson, and Company and the US President’s Emergency Plan for AIDS Relief
Key Indicators Before the PPP (2008–2010) After the PPP (2010–2012)
Sites referring specimens 420 554
Sample transportation mechanism Not standardized, laboratory personnel transport the specimen Ethiopian Postal System, no laboratory personnel
transport specimen in pilot sites
Time needed to transport specimen for
ART-related monitoring after collection
4 h (range, 2–6 h) in Addis Ababa and >6 h (range, 3–14 h) in
other regions
1 h in Addis Ababa (range, 0.5–2 h) and 4 h (range,
1–5 h) in other regions
Specimen-transport containers with
triple-packaging capacity, no,
100 2132 (400 procured by BD and the rest procured
by PEPFAR)
People trained on specimen-referral
system, no.
85 laboratory personnel only 667, including laboratory personnel (n = 586) and
postal workers (n = 81)
Training coverage No structured training in any region except for demonstration
of specimen-transport and standard operating procedures
Standard training module available for all regions
Turnaround timea for ART-related
monitoring
7 d (range, 2–14 d) in Addis Ababa and 10 d (range, 6–21 d) in
Amhara Region
2 d (range, 1–3 d) in Addis Ababa and 5 d (range,
2–6 d) in Amhara Region
GIS mapping of sites No system System installed, with provision of initial trainingb
Abbreviations: ART, antiretroviral therapy; GIS, geographic information system; PEPFAR, US President’s Emergency Plan for AIDS Relief.
a Defined as the time from referral of specimens collected from ART recipients to a laboratory (for monitoring CD4+ T-cell, chemical, and hematological parameters) to receipt of results by the
referring facility. It does not account for the time needed to collect specimens.
b Full implementation and evaluation of GIS mapping is planned for the second phase of the PPP.











Number of Referring Sites
The main goal of the PPP was to improve the specimen-referral
system in the existing facilities. However, it also helped to enroll
more facilities into the specimen-referral network. Prior to the
creation of the PPP, engagement of stakeholders, and imple-
mentation of the training intervention, only 420 sites referred
specimens. However, following the intervention, >554 laborato-
ries referred specimens to 160 testing laboratories for ART
monitoring (Table 1). Effective networking of the 554 health
centers and hospital laboratories is ongoing and includes con-
tinued use of GIS and GPS technology so that the post office can
be instrumental in the timely collection of specimens from
facilities in remote areas, the transport of these specimens to
specialized testing laboratories, and the return of the results
back to each of the referring sites. To establish local capacity,
the PPP customized a curriculum to address the gaps in the
existing specimen referral and results-reporting system for lab-
oratory and postal workers. The training materials are a valuable
resource for the country team to train laboratory and postal
service personnel in future efforts to expand specimen referral
to more facilities.
DISCUSSION
Through the PPP, we documented the feasibility of standardiz-
ing the specimen-transport system in Ethiopia by using a uni-
fied approach for specimen transport through the EPSE and by
providing standard packaging materials. Laboratory and postal
office staff were successfully trained on safe sample packaging
and transportation, to protect staff and ensure specimen integ-
rity for accurate diagnosis. Furthermore, we demonstrated that
enhanced local capacity and increased awareness among service
providers led to a significant reduction in turnaround times. Be-
cause testing capacities of laboratories across the laboratory
tiered system are not the same, establishing a functional and
reliable laboratory network is critical to improve patient out-
comes. The specimen-referral system was established to support
laboratory-based monitoring of ART.
Ethiopia is a vast country striving to increase access to quality-
assured, integrated laboratory services as part of the health sector
development plan. The EPHI has developed an integrated na-
tional laboratory strategic master plan to coordinate and guide
the strengthening of laboratory systems [15]. One of the objec-
tives of the strategic plan was to put in place a reliable specimen-
referral system across all regions. The success of the PPP was
based on its strong leadership and emphasis on the host coun-
try’s ownership of joint program planning, implementation,
and evaluation among the parties [16]. By being introduced to
the Ethiopian MOH through CDC-Ethiopia, BD built on the
existing partnership and close working relationship between
the CDC, the Ethiopian MOH, and local partners. The CDC’s
prior experience in the implementation of the national labora-
tory strategic master plans and in working with the Ethiopian
MOH and ensuring country ownership was key to the success
of the program. Furthermore, the effective country engagement
through a local supporter at the EPHI, the leveraging of core
competencies of each partner, and the leadership and steward-
ship on the national, regional, and district levels were crucial
for program execution for a better health system [17].
Maintaining the safety and integrity of specimens is a critical
element in transporting biological specimens for analysis and
accurate and reliable diagnosis. The importance of awareness
and training to prevent healthcare worker exposure to biological
materials and infection cannot be overemphasized [18]. WHO
guidelines recommend that packaging of infectious materials
for transport must adhere to standards and be designed to min-
imize the potential for damage during transportation. In addi-
tion, the packaging must ensure the integrity of the materials
and timely processing of specimens [19]. The PPP took the
lead in conceptualizing and designing a tailor-made course
for the laboratory and postal staff and training them on biosaf-
ety and accurate packaging and transport practices for infec-
tious materials. The PPP also provided standard transport
containers to ensure the safety and integrity of specimens.
The prompt diagnosis and initiation of ART among patients
with HIV/AIDS reduces transmission, morbidity, and mortality
[20–22]. The laboratory has an important role in ensuring that
quality results are available in a timely manner to enable care
providers to initiate treatment. The PPP enhanced capacity to
receive specimens transported under optimum conditions and
for timely and accurate reports of patient results. One of the
benefits of the PPP’s specimen-referral program was the reduc-
tion in turnaround time, which improved the timely initiation
and cost-effectiveness of treatment. In particular, this increased
access to CD4+ T-cell testing, for staging and early initiation of
ART, and to laboratory-based ART monitoring. As greater
access to quality laboratory services continues to increase, an
efficient specimen-referral system, along with innovative tech-
nology, such as point-of-care testing, would further decrease
turnaround time and increase patient access to treatment.
The successful implementation of the PPP led to the estab-
lishment of the first innovative and sustainable transport
chain by using the postal system to send specimens from remote
sites to specialized laboratories and then return the results to the
point of care. Ethiopia used the PPP collaboration to develop a
system to refer multiple types of specimens. The PPP built on
the success the EPSE used throughout the country to transport
specimens for evaluation by the DBS technique for early diag-
nosis of HIV infection in infants.
The increased availability of GIS technology among EPHI
staff improved the institution’s ability to create maps and visu-
alize epidemiological data. Use of the GIS system would further
streamline efficient sample referral because it would be based on
relatively shorter distances between the referring and testing
sites as against regional boundaries. There has been a carryover











effect of the GIS program in strengthening local capacity for dis-
ease surveillance and for public health emergency management.
Despite the successful piloting and roll out of an efficient
sample-referral system, the PPP faced both health system–
associated and country-specific challenges. The lack of adequate
resources in terms of workforce and budget allocations to cover
the national needs was an important limitation, including oper-
ational budgets for specimen-referral and GIS programs. The
PPP-supported trainings were delivered in English, which pre-
sented a significant language barrier to many trainees, especially
postal workers in areas where the predominant language is Am-
haric. Although Ethiopia has focused on making the program
sustainable, through training-of-trainer’s workshops for local
capacity building and engagement of regional health bureaus
and partners to increase country ownership, longer-term sourc-
es of funding for all PPP activities will be key to scaling up these
interventions to optimize HIV services delivery and health sys-
tems strengthening. The effective use of the EPSE with offices
and services in 800 districts thus bringing it closer to most re-
ferring facilities at reasonable cost. Furthermore, more engage-
ment of regional health bureaus to coordinate the referral
network, integration of the specimen-referral system, transla-
tion of standard operating procedures and training materials
to local languages, and discovery of local and alternative financ-
ing schemes are critical for the sustainability of the specimen-
referral system. A limitation of our study was the nonsystematic
collection of data prior to and after the intervention on the rate
of sample rejection, which would have allowed analysis of the
effect of the intervention on the rejection rate. However, it is
noteworthy that the other key indicators that were assessed all
showed improvements following intervention by the PPP.
In summary, the integration of technology, local workforce
training, and the healthcare infrastructure significantly enhanced
specimen referral and results-reporting networks by increasing
the number of referring sites and decreasing turnaround times
for ART-related monitoring. Joint planning among the Ethiopian
MOH/EPHI, the CDC, and BD, in addition to strong leadership
provided by the EPHI and the clear outline of objectives by the
national laboratory strategic master plan, was crucial for improving
the specimen-referral system and increasing access to quality
laboratory services. The successful implementation of this initiative
may be relevant to other areas of laboratory-system strengthening
and may encourage governments and businesses to increasingly
support the creation of more PPPs to strengthen healthcare
systems.
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